Latest News - Boston Scientific

Top Corporates Hub

Boston Scientific

BSX | NYSE | United States
101
+33
Rank
$112.32B
Market Cap
$16.74B
+$ 2.5B
+17.56%
Revenue
$2.28B
+$ 0.3B
+15.15%
Earnings
53K
+5K
+10.42%
Employees
Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know

08.10.2026 12:00

Recently, Zacks.com users have been paying close attention to Boston Scientific (BSX). This makes it worthwhile to examine what the stock has in store.

Read More

Boston Scientific names Joseph Fitzgerald as chief operating officer

08.10.2026 10:55

Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.

Read More

Boston Scientific names Joseph Fitzgerald as chief operating officer

08.10.2026 10:55

Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.

Read More

1 Safe-and-Steady Stock to Research Further and 2 Facing Challenges

08.10.2026 08:08

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Read More

Why Is Boston Scientific (BSX) Reorganizing Into Three Segments Under A New COO?

08.10.2026 04:29

Boston Scientific (NYSE: BSX) appointed Joseph M. Fitzgerald as executive vice president and chief operating officer, effective January 1, 2027. The company plans to reorganize its global operations into three reportable segments: Interventional Therapies, Rhythm Solutions, and MedSurg. Fitzgerald is expected to oversee the transition to the new segment structure as part of a broader operational realignment. The leadership change and shift to Interventional Therapies, Rhythm Solutions, and...

Read More

Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer

07.10.2026 10:00

Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Joseph M. Fitzgerald to executive vice president and chief operating officer (COO), effective Jan. 1, 2027. In this role, Fitzgerald will oversee the company's global operations, business units and regions.

Read More

Barclays Initiates Coverage On Boston Scientific with Equal-Weight Rating, Announces Price Target of $48

07.10.2026 08:18

Barclays analyst Christopher Pasquale initiates coverage on Boston Scientific (NYSE:BSX) with a Equal-Weight rating and announces Price Target of $48.

Read More

Boston Scientific Appoints Joseph M. Fitzgerald As EVP And COO, Effective January 1, 2027

07.10.2026 06:05

Fitzgerald currently serves as executive vice president and group president, Cardiovascular, Boston Scientific. Under his leadership, the company has strengthened its portfolio through organic innovation, strategic

Read More

Boston Scientific (BSX) Faces A Recall, Is The 28% Undervaluation Still Compelling?

28.09.2026 13:11

Boston Scientific (BSX) is in focus after initiating a Class II recall of its StoneSmart Connect Console power adapters, affecting 982 units distributed across the US and multiple international markets. Against this recall backdrop, Boston Scientific’s share price has eased 1.7% over the last trading day and is down 6.2% over the past month, while the 1‑year total shareholder return has declined 54.7%, signaling fading momentum despite a small 2.9% gain on a 90‑day share price basis. Scan how...

Read More

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

28.09.2026 12:30

According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Read More

What Do Boston Scientific (BSX) Recall And Executive Retirement Mean For Investors?

28.09.2026 12:07

Boston Scientific (NYSE: BSX) has started a voluntary global recall of its StoneSmart Connect Console over a power adapter safety issue. The company is informing hospitals and healthcare providers worldwide about the recall and advising on identification and return of affected units. Arthur C. Butcher, who oversees key endoscopy and urology portfolios, has notified Boston Scientific of his decision to retire. The recall of StoneSmart Connect and Arthur C. Butcher's retirement only capture...

Read More

2 Value Stocks with Exciting Potential and 1 We Avoid

22.09.2026 09:25

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Read More

2 Value Stocks with Exciting Potential and 1 We Avoid

22.09.2026 09:25

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Read More

Citi downgrades Boston Scientific on uncertain recovery path

17.09.2026 11:59

Investing.com -- Citi has downgraded Boston Scientific to Neutral from Buy, citing an uncertain recovery path after a string of setbacks this year.

Read More

Boston Scientific (BSX) Recalls LUX Dx Cardiac Monitor Over Delayed AF Alerts

17.09.2026 02:11

Boston Scientific (NYSE:BSX) has initiated a voluntary global recall of its LUX-Dx Insertable Cardiac Monitor System and software over atrial fibrillation Burden Alert delays. The recall targets multiple versions of LUX-Dx hardware and associated software that may postpone detection alerts for atrial arrhythmias used in patient monitoring. The US FDA has taken enforcement interest in the action, underscoring regulatory scrutiny of the cardiac monitoring platform and its alert...

Read More

Boston Scientific: A Great Company At A Deeply Discounted Price (Rating Upgrade)

15.09.2026 07:30

Boston Scientific is a leading medical technology company produces high-performance solutions that address patient needs. Read why BSX stock is a strong buy.

Read More

Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.

13.09.2026 19:31

Boston Scientific Corporation (NYSE:BSX) fell 2.3% in early trading on September 8, 2026, after disclosing that an August 25 cyberattack disrupted manufacturing and shipping. The company stated it is unlikely to meet its previously issued third-quarter and full-year 2026 guidance for net sales and adjusted earnings per share. Though operations have since resumed, the incident […]

Read More

1 of Wall Street’s Favorite Stocks with Promising Prospects and 2 Facing Challenges

10.09.2026 12:41

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Read More

Boston Scientific Corporation (BSX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

10.09.2026 12:37

Boston Scientific Corporation (BSX) Wells Fargo 21st Annual Healthcare Conference September 10, 2026 8:00 AM EDTCompany ParticipantsMichael Mahoney -...

Read More

Alpha Buying: 4 Falling Knives Insiders Are Buying

10.09.2026 12:16

There are dozens of reasons corporate executives sell shares. They may need money to pay taxes, buy a house, settle a divorce, diversify their wealth, or fund a new boat they will use three times before deciding they

Read More